Related Experiment Video

Updated: Jul 19, 2026

Heterokaryon Technique for Analysis of Cell Type-specific Localization
09:31

Heterokaryon Technique for Analysis of Cell Type-specific Localization

Published on: March 11, 2011

Nucleocytoplasmic shuttling of the retinoblastoma tumor suppressor protein via Cdk phosphorylation-dependent nuclear

Wan Jiao1, Jashodeep Datta, Huei-Min Lin

  • 1Cell Cycle and Human Diseases Group, Diabetes Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.

The Journal of Biological Chemistry
|October 18, 2006
PubMed

Insights

Retinoblastoma (RB) protein normally in the nucleus moves to the cytoplasm due to Cdk mutations. Inhibiting Exportin1 or Cdk activity can restore RB

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The retinoblastoma (RB) protein is a crucial tumor suppressor that regulates cell proliferation.
  • RB pathway mutations and elevated Cyclin-dependent kinase (Cdk) activity are prevalent in human cancers, leading to RB inactivation.
  • Understanding Cdk's precise role in RB function is vital for developing effective anticancer therapies.

Purpose of the Study:

  • To investigate a novel function of Cdks in regulating the subcellular localization of the RB protein.
  • To explore the mechanism by which RB is mislocalized and identify potential therapeutic targets.

Main Methods:

  • Analysis of RB subcellular localization in cells with Cdk4 mutations.
  • Investigation of the role of the Exportin1 pathway in RB nuclear export.
  • Assessment of the effects of Exportin1 inhibition, Cdk activity reduction, and Cdk-dependent phosphorylation site mutations on RB localization.

Main Results:

  • Cells with Cdk4 mutations exhibit significant cytoplasmic mislocalization of the normally nuclear RB protein.
  • This mislocalization represents a mechanism to bypass RB-mediated growth suppression via altered nucleocytoplasmic trafficking through Exportin1.
  • Inhibiting Exportin1, reducing Cdk activity, or mutating Cdk-dependent phosphorylation sites restores RB to the nucleus and re-establishes its tumor-suppressive function.

Conclusions:

  • RB tumor suppression can be circumvented by phosphorylation-dependent enhancement of nuclear export mediated by Cdks and Exportin1.
  • Tumor cells can exploit protein transport machinery to inactivate tumor suppressors.
  • Protein transport pathways represent a viable therapeutic target for cancer treatment.

More Related Videos

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Nuclear Protein Sorting01:34

Nuclear Protein Sorting

Nuclear protein sorting is the selective trafficking of histones, polymerases, gene regulatory proteins into the nucleus and exporting RNAs and ribosomes to the cytosol. It is a tightly controlled process that regulates gene expression within a cell.
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Directionality of Nuclear Transport01:42

Directionality of Nuclear Transport

Ras-related nuclear protein or Ran is a small G protein that cycles between its GTP and GDP bound states. Ran specific regulators, a Ran GTPase Activating Protein or RanGAP present in the cytosol and a Ran guanine nucleotide exchange factor or RanGEF present inside the nucleus regulate GTP/GDP exchange. A high concentration of GTP inside the cells, in addition to this asymmetric distribution of  Ran-specific regulators, leads to a higher RanGTP concentration inside the nucleus. This...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...